Trial Profile
A study assessing relation between serum level of rituximab at the start of retreatment and clinical response at Months 6 in patients with rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Jul 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 09 Jul 2015 New trial record